rHGH
Showing 1 - 25 of 104
Evaluation of Growth Hormone in Children in China(CGLS)
Recruiting
- Childhood Short Stature
- Polvethylene glycol recombinant human growth hormone injection (PEG-rhGH) or recombinanthuman growth hormone injection (rhGH)
-
Wuhan, Hubei, ChinaTongjiHospital
Oct 31, 2023
Pediatric Growth Hormone Deficiency (PGHD) Trial in Chengdu (PEG-rhGH with new preparation, PEG-rhGH with present preparation)
Not yet recruiting
- Pediatric Growth Hormone Deficiency (PGHD)
- PEG-rhGH with new preparation
- PEG-rhGH with present preparation
-
Chengdu, Sichuan, ChinaChengdu Xinhua Hospital affiliated to North Sichuan Medical Coll
Nov 12, 2023
Pediatric Growth Hormone Deficiency (PGHD) Trial in Chengdu (PEG-rhGH with new preparation, PEG-rhGH with present preparation)
Not yet recruiting
- Pediatric Growth Hormone Deficiency (PGHD)
- PEG-rhGH with new preparation
- PEG-rhGH with present preparation
-
Chengdu, Sichuan, ChinaChengdu Xinhua Hospital affiliated to North Sichuan Medical Coll
Nov 12, 2023
Idiopathic Short Stature, Small for Gestational Age, Turner Syndrome Trial in China (YPEG-rhGH, rhGH)
Active, not recruiting
- Idiopathic Short Stature
- +2 more
- YPEG-rhGH
- rhGH
-
Hefei, Anhui, China
- +18 more
Apr 27, 2023
Vesiculogenesis in Children With GH Deficiency (VESCIGHTP)
Recruiting
- GH Deficiency
- rhGH
-
Milan, ItalyIstituto Auxologico Italiano IRCCS
Feb 26, 2023
Facioscapulohumeral Muscular Dystrophy Trial in Rochester (Testosterone Enanthate, Somatropin)
Completed
- Facioscapulohumeral Muscular Dystrophy
- Testosterone Enanthate
- Somatropin
-
Rochester, New YorkUniversity of Rochester
Jun 7, 2022
Small for Gestational Age Infant, Growth Hormone Treatment, Cognitive Developmental Disorder Trial (PEG-rhGH)
Not yet recruiting
- Small for Gestational Age Infant
- +2 more
- (no location specified)
Dec 16, 2021
Obesity Trial in Boston (recombinant human growth hormone (rhGH), Placebo)
Completed
- Obesity
- recombinant human growth hormone (rhGH)
- Placebo
-
Boston, MassachusettsMassachusetts General Hospital
Oct 22, 2021
Phelan-McDermid Syndrome, Growth Hormone Treatment Trial in Wuxi (recombinant human growth hormone, Saline)
Completed
- Phelan-McDermid Syndrome
- Growth Hormone Treatment
- recombinant human growth hormone
- Saline
-
Wuxi, Jiangsu, ChinaAffiliated Hospital of JiangNan University, Department of Pediat
Oct 7, 2022
Phelan-McDermid Syndrome, Autism Spectrum Disorder (ASD) Trial in New York (Growth Hormone, Saline)
Recruiting
- Phelan-McDermid Syndrome
- Autism Spectrum Disorder (ASD)
- Growth Hormone
- Saline
-
New York, New YorkSeaver Autism Center for Research & Treatment
Jul 24, 2022
Growth Hormone Deficiency Trial in Charlottesville (LUM-201)
Enrolling by invitation
- Growth Hormone Deficiency
-
Charlottesville, VirginiaUniversity of Virginia Health System
Mar 9, 2022
GH Treatment in Patients With TBI and AGHD
Active, not recruiting
- Adult-Onset Growth Hormone Deficiency
-
Seattle, WashingtonVA Puget Sound Health Care System
Aug 2, 2022
Anorexia Nervosa, Osteopenia, Osteoporosis Trial in Boston (Recombinant Human Growth Hormone, Placebo for Recombinant Human
Completed
- Anorexia Nervosa
- +3 more
- Recombinant Human Growth Hormone
- Placebo for Recombinant Human Growth Hormone
-
Boston, MassachusettsMassachusettes General Hospital
Aug 31, 2020
Growth Hormone Deficiency Trial in Worldwide (TV-1106, Placebo)
Adults With Prader-Willi Syndrome (ETABIOLPWS)
Recruiting
- Prader-Willi Syndrome
- Multidisciplinary metabolic rehabilitation program
-
Oggebbio, Verbania, ItalyIstituto Auxologico Italiano IRCCS, Site Piancavallo
Mar 8, 2023
Growth Hormone Deficiency Trial in Worldwide (LUM-201, rhGH Norditropin® pen (34 µg/kg))
Recruiting
- Growth Hormone Deficiency
- LUM-201
- rhGH Norditropin® pen (34 µg/kg)
-
Birmingham, Alabama
- +52 more
Jan 30, 2023
Insulin Resistance, Prediabetic State, Non-Alcoholic Fatty Liver Disease Trial in New York (drug, other, dietary supplement,
Not yet recruiting
- Insulin Resistance
- +3 more
- Insulin human
- +11 more
-
New York, New YorkColumbia University Irving Medical Center
Nov 6, 2023
Insulin-like Growth Factor-1 Deficiency Trial in Brisbane (NutropinAq® (Somatropin [rDNA origin]), Increlex® (Mecasermin [rDNA
Terminated
- Insulin-like Growth Factor-1 Deficiency
- NutropinAq® (Somatropin [rDNA origin])
- Increlex® (Mecasermin [rDNA origin] injection) + NutropinAq® (Somatropin [rDNA origin])
-
Brisbane, CaliforniaIpsen
Sep 5, 2019
Insulin Resistance, Prediabetic State, Hyperinsulinemia Trial in New York (drug, other, dietary supplement, device)
Recruiting
- Insulin Resistance
- +4 more
- Insulin human
- +8 more
-
New York, New YorkColumbia University Irving Medical Center
Feb 2, 2023
Recombinant Human Growth Hormone on ADHD Characteristics in
Recruiting
- Growth Hormone Deficiency
- +2 more
- Questionnaires
-
Zrifin, IsraelAssaf Haroffeh Medical center
Aug 7, 2022
Brain Injury Associated Fatigue and Altered Cognition (BIAFAC)
Enrolling by invitation
- Traumatic Brain Injury
-
Galveston, TexasUniversity of Texas Medical Branch
Jan 30, 2023